JEREMY BEARFIELD: Open Payments
NPI 1326337437 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$565 in 32 payments from 12 companies in 2025. Trend: 2023 $3,525 · 2024 $1,070 · 2025 $565
Food & beverage: $565
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 16 | $232 |
| Novartis Pharmaceuticals Corporation | 2 | $46 |
| Exact Sciences Corporation | 2 | $38 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $36 |
| GlaxoSmithKline, LLC. | 2 | $33 |
| Inspire Medical Systems, Inc. | 1 | $32 |
| Lilly USA, LLC | 2 | $31 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $31 |
| PFIZER INC. | 1 | $28 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
Products named: OTEZLA, LEQVIO, Cologuard Collection Kit, JARDIANCE, TRELEGY ELLIPTA, INSPIRE, MOUNJARO, JOURNAVX.
Industry payments across NV — which companies pay providers there.
